AR088035A1 - Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacion - Google Patents
Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacionInfo
- Publication number
- AR088035A1 AR088035A1 ARP120103542A ARP120103542A AR088035A1 AR 088035 A1 AR088035 A1 AR 088035A1 AR P120103542 A ARP120103542 A AR P120103542A AR P120103542 A ARP120103542 A AR P120103542A AR 088035 A1 AR088035 A1 AR 088035A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- methods
- dehydration processes
- damage caused
- maltotrious
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 7
- 230000018044 dehydration Effects 0.000 title abstract 5
- 238000006297 dehydration reaction Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 abstract 3
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 abstract 3
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 abstract 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 abstract 3
- 230000006866 deterioration Effects 0.000 abstract 2
- 238000000605 extraction Methods 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Detergent Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Composiciones que comprenden maltotriosa. En ciertas formas de realización, las composiciones comprenden maltotriosa y por lo menos un componente, tal como un microorganismo vivo, cuya función es sometida a deterioro por los procesos de deshidratación. Métodos para la inhibición del daño provocado por deshidratación. En algunas formas particulares de realización, el método incluye la preparación de una composición que comprende maltotriosa y por lo menos un componente cuya función es sometida a deterioro por los procesos de deshidratación y la extracción de agua de la composición mediante uno o más procesos de deshidratación.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/270,607 US20130089638A1 (en) | 2011-10-11 | 2011-10-11 | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR088035A1 true AR088035A1 (es) | 2014-05-07 |
Family
ID=46846027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120103542A AR088035A1 (es) | 2011-10-11 | 2012-09-26 | Composiciones que comprenden maltotriosa y metodos para el uso de las mismas para inhibir el daño provocado por los procesos de deshidratacion |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20130089638A1 (es) |
| EP (1) | EP2765872A1 (es) |
| CN (2) | CN103929979A (es) |
| AR (1) | AR088035A1 (es) |
| BR (1) | BR112014008498A2 (es) |
| CA (1) | CA2852109A1 (es) |
| CO (1) | CO6940418A2 (es) |
| EC (1) | ECSP14000460A (es) |
| HK (2) | HK1199797A1 (es) |
| MX (1) | MX2014004060A (es) |
| PE (1) | PE20142080A1 (es) |
| PH (1) | PH12014500795A1 (es) |
| RU (1) | RU2014110708A (es) |
| SG (1) | SG11201400696XA (es) |
| TW (2) | TW201822640A (es) |
| WO (1) | WO2013055463A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6823601B2 (ja) | 2015-10-30 | 2021-02-03 | 株式会社ヤクルト本社 | 微生物乾燥菌体の製造方法 |
| EP3524051A1 (en) * | 2018-02-12 | 2019-08-14 | DuPont Nutrition Biosciences ApS | Matricial microencapsulation compositions |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3792183A (en) * | 1971-08-10 | 1974-02-12 | Nabisco Inc | Cereal coating composition and process |
| JPS60258125A (ja) * | 1984-06-06 | 1985-12-20 | Hayashibara Biochem Lab Inc | 蛋白性生理活性物質を含有する水溶性乾燥物 |
| US4814267A (en) * | 1984-09-18 | 1989-03-21 | Michigan Biotechnology Institute | Method for preparing high conversion syrups and other sweeteners |
| ATE100855T1 (de) * | 1988-11-10 | 1994-02-15 | Takeda Chemical Industries Ltd | Saure urease-zubereitungen fuer alkoholische getraenke. |
| US5145697A (en) * | 1989-04-26 | 1992-09-08 | Mpy Foods, Inc. | Instant yogurt composition and process |
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| EP1961312A3 (en) | 1991-01-24 | 2010-03-31 | Martek Biosciences Corporation | Microbial oil mixture and uses thereof |
| AU659645B2 (en) * | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
| US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
| JPH09505516A (ja) | 1993-11-17 | 1997-06-03 | ニロ・ホールディング・アー／エス | 凝集塊粉体を製造するための噴霧乾燥方法及び装置 |
| FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| ES2243965T3 (es) * | 1996-07-09 | 2005-12-01 | Societe Des Produits Nestle S.A. | Procedimiento de secado mediante pulverizacion. |
| US6223455B1 (en) | 1999-05-03 | 2001-05-01 | Acusphere, Inc. | Spray drying apparatus and methods of use |
| US6463675B1 (en) | 1999-09-29 | 2002-10-15 | Niro A/S | Process and a plant for spray drying |
| US6322994B1 (en) * | 1999-11-04 | 2001-11-27 | Genetix Limited | Method of freeze-drying organisms |
| EP1260227A1 (en) * | 2001-05-23 | 2002-11-27 | Societe Des Produits Nestle S.A. | Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| FR2829147B1 (fr) * | 2001-08-30 | 2003-12-12 | Agronomique Inst Nat Rech | Procede de preparation d'une composition lyophilisee contenant des bacteries lactiques a viabilite et activite bacteriennes ameliorees lors d'un stockage a temperature ambiante et composition obtenue |
| US6838097B1 (en) * | 2001-12-14 | 2005-01-04 | Stephen Tsengas | Pet food product |
| SI1565547T2 (sl) * | 2002-06-28 | 2013-02-28 | Biosearch S.A. | Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba |
| WO2006029467A1 (en) * | 2004-09-16 | 2006-03-23 | Btf Pty Ltd | Rapid freeze drying process |
| EP1656930A1 (en) | 2004-11-10 | 2006-05-17 | Basilea Pharmaceutica AG | Stabilized freeze-dried formulation for cephalosporin derivatives |
| WO2006067647A2 (en) * | 2004-12-21 | 2006-06-29 | Firmenich Sa | Encapsulated polyunsaturated fatty acids |
| US20090065745A1 (en) * | 2005-03-31 | 2009-03-12 | Hirotsugu Kido | Anti-degradation agent |
| US7572474B2 (en) | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
| WO2007058027A1 (ja) * | 2005-11-18 | 2007-05-24 | Idemitsu Kosan Co., Ltd. | バチルス・チューリンゲンシスを含む有害菌の防除剤 |
| JP4889317B2 (ja) * | 2006-02-17 | 2012-03-07 | オリエンタル酵母工業株式会社 | マルトトリオース高含有組成物及びその製造方法 |
| EP1903291A1 (en) | 2006-09-19 | 2008-03-26 | Ima-Telstar S.L. | Method and system for controlling a freeze drying process |
| JP2011507518A (ja) * | 2007-12-20 | 2011-03-10 | アボット・ラボラトリーズ | 安定な栄養粉末 |
| CN102014873A (zh) * | 2008-02-25 | 2011-04-13 | 诺瓦瓦克斯股份有限公司 | 糖玻璃化的病毒样颗粒 |
| CN101313715A (zh) * | 2008-07-09 | 2008-12-03 | 内蒙古蒙牛乳业（集团）股份有限公司 | 一种添加维生素适用于12到36个月的婴儿液态乳 |
| US20110070334A1 (en) * | 2009-09-20 | 2011-03-24 | Nagendra Rangavajla | Probiotic Stabilization |
| BR112013003244B1 (pt) * | 2010-08-13 | 2018-07-17 | Advanced Bionutrition Corp | composição seca estabilizante para material biológico, seu método de preparação, e formulação de carreamento oral |
-
2011
- 2011-10-11 US US13/270,607 patent/US20130089638A1/en not_active Abandoned
-
2012
- 2012-09-06 HK HK15100322.2A patent/HK1199797A1/xx unknown
- 2012-09-06 CN CN201280050046.3A patent/CN103929979A/zh active Pending
- 2012-09-06 MX MX2014004060A patent/MX2014004060A/es unknown
- 2012-09-06 CN CN201710940893.1A patent/CN107647394A/zh active Pending
- 2012-09-06 PE PE2014000502A patent/PE20142080A1/es not_active Application Discontinuation
- 2012-09-06 CA CA2852109A patent/CA2852109A1/en not_active Abandoned
- 2012-09-06 EP EP12758967.9A patent/EP2765872A1/en not_active Withdrawn
- 2012-09-06 PH PH1/2014/500795A patent/PH12014500795A1/en unknown
- 2012-09-06 WO PCT/US2012/053855 patent/WO2013055463A1/en not_active Ceased
- 2012-09-06 BR BR112014008498A patent/BR112014008498A2/pt not_active IP Right Cessation
- 2012-09-06 RU RU2014110708/13A patent/RU2014110708A/ru not_active Application Discontinuation
- 2012-09-06 SG SG11201400696XA patent/SG11201400696XA/en unknown
- 2012-09-14 TW TW106137638A patent/TW201822640A/zh unknown
- 2012-09-14 TW TW101133819A patent/TW201325460A/zh unknown
- 2012-09-26 AR ARP120103542A patent/AR088035A1/es unknown
-
2014
- 2014-04-16 CO CO14082669A patent/CO6940418A2/es not_active Application Discontinuation
- 2014-05-09 EC ECIEPI2014460A patent/ECSP14000460A/es unknown
-
2018
- 2018-07-31 HK HK18109830.5A patent/HK1250315A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20130089638A1 (en) | 2013-04-11 |
| PH12014500795A1 (en) | 2022-12-02 |
| CA2852109A1 (en) | 2013-04-18 |
| WO2013055463A1 (en) | 2013-04-18 |
| EP2765872A1 (en) | 2014-08-20 |
| TW201325460A (zh) | 2013-07-01 |
| HK1199797A1 (en) | 2015-07-24 |
| CN107647394A (zh) | 2018-02-02 |
| CO6940418A2 (es) | 2014-05-09 |
| SG11201400696XA (en) | 2014-08-28 |
| BR112014008498A2 (pt) | 2017-04-11 |
| TW201822640A (zh) | 2018-07-01 |
| ECSP14000460A (es) | 2015-06-30 |
| MX2014004060A (es) | 2014-07-09 |
| CN103929979A (zh) | 2014-07-16 |
| PE20142080A1 (es) | 2014-12-24 |
| RU2014110708A (ru) | 2015-11-20 |
| HK1250315A1 (zh) | 2018-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000882A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15). | |
| ECSP14004812A (es) | Triazolopiridinas sustituidas | |
| ECSP14016162A (es) | Combinaciones de compuestos activos | |
| MX2019007709A (es) | Analogos de compstatina de celula reactiva, de accion prolongada u objetivos y composiciones y metodos relacionados. | |
| CL2014000630A1 (es) | Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc. | |
| GT201400043A (es) | Imidazopiridazinas sustituidas con amino | |
| UY35040A (es) | Pirrolopirimidinilamino-benzotiazolonas sustituidas | |
| CR20150250A (es) | Nuevos derivados de piridina | |
| ECSP13013011A (es) | Triazolopiridinas | |
| CR20120357A (es) | Composición que comprende un pesticida y un alcoxilato de 2-propilheptilamina | |
| CR20160433A (es) | Nuevos compuestos | |
| CR20150447A (es) | Nuevos derivados de pirazol | |
| CO6640327A2 (es) | Compuestos de pirazol como inhibidores del receptor sigma | |
| SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
| MX2013004104A (es) | Uso de una composicion que comprende un peptido antimicrobiano como un conservador de alimentos. | |
| NI201400042A (es) | 2 - tiopirimidinonas | |
| MX2016000211A (es) | Cd33 soluble para tratar sindromes mielodisplasicos (mds). | |
| DOP2016000118A (es) | Tienopirimidinas como inhibidores mknk1 y mknk2 | |
| NI201600006A (es) | Pirazolo-piridinaminas sustituidas | |
| DOP2016000268A (es) | Compuestos de azol amidosustituidos como inhibidores de tnks1 y/o tnks2 | |
| PE20141584A1 (es) | Uso de un inhibidor de aromatasa para el tratamiento del hipogonadismo y enfermedades relacionadas | |
| CL2013002903A1 (es) | Composicion que comprende azadiractina; metodo para el tratamiento anti-macroincrustacion de al menos un polimeros; y su uso. | |
| CL2016002532A1 (es) | Compuestos derivados de diheterociclo enlazado a cicloalquilo con actividad inhibidora de gls1 uso en el tratamiento de crecimiento celular anormal, tal como cáncer composición farmacéutica que los contiene | |
| AR102376A1 (es) | Método de tratamiento para anti-brote de tubérculos con cantidad reducida de cipc | |
| CR20160432A (es) | Inhibidores de las vías de señalización de wnt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |